Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Tutorial
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ATRA
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
ATRA
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

ATRA Similar Chart Price Prediction

The price of ATRA is predicted to go up 13.97%, based on the high correlation periods with BNED. The similarity of these two price pattern on the periods is 97.16%.

stocks logo

ATRA

stocks logo

BNED

Up: 13.97%Similarity: 97.16%

ATRA Revenue Forecast

ATRA EPS Forecast

ATRA FAQs

What is bull’s view on ATRA?

ATRA stock has a bullish outlook with a price target of $17, as maintained by Canaccord Genuity on January 17, 2025. The analyst highlights the potential resolution of FDA issues related to Ebvallo within six months, despite delays in approval and CAR-T development concerns. The current price of $8.26 suggests a significant upside of over 100%.

What is bear's view on ATRA?

ATRA stock is bearish due to significant regulatory setbacks. The FDA's rejection of its immunotherapy Ebvallo and subsequent clinical holds have caused shares to plummet, currently trading at $8.61, down from $13 earlier this year. Additionally, the company's decision to cut 50% of its workforce signals financial strain and uncertainty in resolving manufacturing compliance issues.

What is ATRA revenue forecast for next quarter？

The market consensus for ATRA's revenue in the upcoming quarter is projected to be approximately $5.067M USD.

What is ATRA eps forecast for next quarter？

The market consensus for ATRA's eps in the upcoming quarter is projected to be approximately $3.94 USD.

ATRA VS S&P500

Ask Intellectia about ATRA

ATRA Analyst's Forecast

John Newman

Canaccord Genuity

Strong Buy

2025-01-17

Price Target

$21 → $17

Upside

+151.11%

Canaccord lowered the firm's price target on Atara Biotherapeutics to $17 from $21 and keeps a Buy rating on the shares. The firm noted Atara received a Complete Response Letter (CRL) for Ebvallo on inspection findings from a third-party manufacturer, which we think can be resolved, with a 6-month review on resubmission. The target was reduced due to delayed Ebvallo approval and the potential to halt CAR-T development 1Q25.
Tony Butler

Rodman & Renshaw

Strong Buy

2024-12-20

Price Target

$25

Upside

+121.73%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free

Hot Stocks

stocks logo

COLM

Columbia Sportswear Co

$90.74
0.49%
stocks logo

CBT

Cabot Corp

$84.47
-1.22%
stocks logo

BWIN

Baldwin Insurance Group Inc

$39.18
-2.66%
stocks logo

ACA

Arcosa Inc

$92.96
-3.87%
stocks logo

VRNS

Varonis Systems Inc

$42.97
-0.28%
stocks logo

LOPE

Grand Canyon Education Inc

$181.7
-2.97%
stocks logo

OPCH

Option Care Health Inc

$32
-1.20%
stocks logo

PHI

PLDT Inc

$23.9
-0.04%
stocks logo

BOOT

Boot Barn Holdings Inc

$128.33
-2.93%
stocks logo

SHAK

Shake Shack Inc

$108.72
-12.05%